Professional Summary

Professional Overview

Marc Credi is an experienced Senior Lead Clinical Trial Leader at the Novartis Institutes for BioMedical Research (NIBR) in Cambridge, Massachusetts. With over 20 years of expertise in the pharmaceutical and biotechnology industries, he specializes in leading complex clinical trials and driving the successful development of innovative therapies.

Experience Summary

Current Role

As the Senior Lead Clinical Trial Leader at NIBR, Marc is responsible for overseeing the execution of multi-site, global clinical trials. He manages cross-functional teams, ensures adherence to regulatory requirements, and implements strategies to optimize trial efficiency and data quality. Under his leadership, several of NIBR's clinical programs have achieved key milestones, contributing to the advancement of the company's drug development pipeline.

Career Progression

Prior to his current role, Marc held progressive positions at NIBR, serving as a Lead Clinical Trial Leader and Clinical Trial Leader II. He has also held senior-level roles at AVEO Pharmaceuticals, Inc. and Genzyme, where he demonstrated his ability to effectively manage clinical research operations and drive the successful completion of clinical trials.

Academic Background

Marc holds a Bachelor of Science degree in Biology from the University of Massachusetts, Amherst, where he graduated with distinction.

Areas of Expertise

• Clinical trial design, implementation, and management

• Cross-functional team leadership and collaboration

• Regulatory compliance and quality assurance

• Data analysis and reporting

• Stakeholder engagement and communication

Professional Impact

Throughout his career, Marc has been instrumental in the successful advancement of numerous clinical programs, contributing to the development of novel therapies that have the potential to improve patient outcomes. His strong technical expertise, coupled with his ability to effectively lead diverse teams, has earned him a reputation as a respected and influential leader within the pharmaceutical industry.

Conclusion

With his extensive experience, proven track record of success, and deep understanding of the clinical research landscape, Marc Credi is a valuable asset to the Novartis Institutes for BioMedical Research. He is committed to driving innovation and accelerating the development of life-changing therapies that address unmet medical needs.